Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Tafasitamab + Zanubrutinib for Chronic Lymphocytic Leukemia
Recruiting1 awardPhase 2
Miami, Florida
This trial tests if two drugs together can help treat CLL/SLL. One drug stops cancer cells from multiplying, the other stops cancer cell growth and spread. Together, they may kill more cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service